Back to Search
MELANIE BORON, PHARMD
PHARMD
Pharmacist
NPI: 1194270546Individual
Specialties, Licenses & Credentials
Research & Publications (8)
A novel active respiratory syncytial virus surveillance system in the United States: variability in the local and regional incidence of infection.
PMID 18989237·Pediatr Infect Dis J·2008
8-other
Improved outcomes with home-based administration of palivizumab: results from the 2000-2004 Palivizumab Outcomes Registry.
PMID 18776822·Pediatr Infect Dis J·2008
8-other
Use of Palivizumab for prevention of hospitalization as a result of respiratory syncytial virus in infants with cystic fibrosis.
PMID 18434935·Pediatr Infect Dis J·2008
8-other
Prevention of hospitalization due to respiratory syncytial virus: results from the Palivizumab Outcomes Registry.
PMID 18368063·J Perinatol·2008
8-other
Palivizumab use in subjects with congenital heart disease: results from the 2000-2004 Palivizumab Outcomes Registry.
PMID 17926087·Pediatr Cardiol·2008
4-observational
Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301.
PMID 16849749·J Clin Oncol·2006
3-trial
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
PMID 15494606·J Natl Cancer Inst·2004
8-other
Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes Registry.
PMID 12746948·Pediatr Pulmonol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5881 SOM CENTER RD
WILLOUGHBY, OH 44094 - Phone
- (440) 946-4357
Quick Facts
- NPI
- 1194270546
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile